http://ideas.eyeconx.net/story.php?title=diabetic-macular-edema-responds-best-to-frequent-ranibizumab Aggressive treatment with ranibizumab during year 3 may be more effective for diabetic macular edema (DME) than less-intensive treatment, according to 3-year outcomes from an ongoing randomized clinical trial published online October 8 in the Archives of Ophthalmology. Ranibizumab is a monoclonal antibody against vascular endothelial growth factor (VEGF), which promotes angiogenesis. The purpose o... Fri, 28 Dec 2012 15:59:47 EST en